NSEAllotment of Securities4d ago · 5 Nov 2026, 10:26 pm

Allotment of Securities

Jubilant Pharmova Limited · JUBLPHARMA

✦ AI SummaryFundraise

Jubilant Pharmova Limited has informed the Exchange regarding allotment of 80,000 securities pursuant to Non Convertible Securities at its meeting held on November 05, 2026. The allotment is part of a private placement basis of Rs. 800 Crores.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jubilant Pharmova Limited has informed the Exchange regarding allotment of 80000 securities pursuant to Non Convertible Securities at its meeting held on November 05, 2026

Attachments (1)

📄

JUBLPHARMA_05112026222548_JPM_-_Allotment_intimation_signed.pdf

pdf

Download →
View document text
November 05, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub: Disclosure under Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Allotment of Non-Convertible Debentures (NCDs) on a private placement basis-Rs.800 Crores Dear Sir/Madam, In continuation to our disclosure dated October 12, 2026, with respect to the issuance of non- convertible debentures on a private placement basis, we hereby inform you that the Finance Committee of the Company at its meeting held today, i.e. Thursday, November 5, 2026, have approved the allotment of 80,000 Unsecured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) of the face value of Rs. 1,00,000 per debenture, issued at par, aggregating to Rs. 800 crore on private placement basis to the successful bidders. Date and time of occurrence of event: November 05, 2026, at 07:30 P.M. (IST). The disclosure required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed herewith as Annexure A. This intimation is also being uploaded on the Company’s website at www.jubilantpharmova.com This is for your information and record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Encl: As above Annexure A No. Particulars Details 80,000 Unsecured, Rated, Listed, Redeemable Non- Convertible Debentures on i. Size of the Issue private placement basis having a face value of Rs. 1,00,000 each, aggregating to Rs. 800 Crore Whether proposed to be listed? If yes, name of the stock ii. Yes, BSE Limited exchange(s) iii. Tenure of the Instrument 3 Years Date of Allotment: 05 November 2026 iv. Date of Allotment and Date of Maturity Date of Maturity: 05 November 2028 v. Coupon/Interest Offered 8.50% p.a. Please refer to the Key vi. Schedule of Payment of Coupon/Interest and Principal Information Document. vii. Charge/Security, if any, created over the assets None Special right/interest/privileges attached to the instrument and viii. Nil changes thereof Delay in payment of interest/principal amount for a period of more ix. than three months from the due date or default in payment of NA interest/principal Details of any letter or comments regarding payment/non-payment x. of interest, principal on due dates, or any other matter concerning Nil the security and/or the assets along with comments thereon, if any Details of redemption of debentures indicating the manner of As mentioned in Point Nos. redemption iii and iv above